Synovial sarcoma: Clinicopathologic features, treatment, and prognosis

Orthopedics

Volumn 30, Issue 12, 2007, Pages 1020-1025

  Siegel, Herrick J ^a   Sessions, Wade ^a   Casillas Jr , Mark A ^a   Said Al Naief, Nasser ^b   Lander, Philip H ^c   Lopez Ben, Robert ^c  

^a Kentucky   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTHRALGIA; CANCER RADIOTHERAPY; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CYTOGENETICS; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; REVIEW; RISK FACTOR; SYNOVIAL SARCOMA;

EID: 38749095208     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20071201-15     Document Type: Review

References (42)

1. Trassard M, Le Doussal V, Hacène K, et al. Prognostic factors in localized primary synovial sarcoma: a multicenter study of 128 adult patients. J Clin Oncol. 2001; 19:525-534.
2. Andrassy RJ, Okcu MF, Despa S, Raney RB. Synovial sarcoma in children: surgical lessons from a single institution and review of the literature. J Am Coll Surg. 2001; 192:305-313.
3. Spillane AJ, A'Hern R, Judson IR, Fisher C, Thomas JM. Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment. J Clin Oncol. 2000; 18:3794-3803.
4. Mazeron JT, Suit HD. Lymph nodes as sites of metastases from sarcomas of soft tissue. Cancer. 1987; 60:1800-1808.
5. Okcu MF, Despa S, Choroszy M, et al. Synovial sarcoma in children and adolescents: thirty three years of experience with multi-modal therapy. Med Pediatr Oncol. 2001; 37:90-96.
6. Winnepenninckx V, DeVos R, Debiec-Rychter M, et al. Calcifying/ossifying synovial sarcoma shows t(X;18) with SSX2 involvement and mitochondrial calcifications. Histopathology. 2001; 38:141-145.
7. Inagaki H, Nagasaka T, Otsuka T, Sugiura E, Nakashima N, Eimoto T. Association of SYT-SSX fusion types with proliferative activity and prognosis in synovial sarcoma. Mod Pathol. 2000; 13:482-488.
8. Sessions WM, Siegel HJ, Casillas MA. Pitfalls in the diagnosis and management of synovial sarcoma. In: The Mid-America Orthopaedic Association Proceedings; April 16-20, 2004; La Quinta, CA.
9. Brodsky JT, Burt ME, Hajdu SI, Casper ES, Brennan MF. Tendosynovial sarcoma: Clinicopathologic features, treatment, and prognosis. Cancer. 1992; 70:484-489.
10. Choong PFM, Prichard DJ, Sim FH, et al. Long-term survival in high grade soft tissue sarcoma: prognostic factors in synovial sarcoma. Int J Oncol. 1995; 7:161-169.
11. Williard WC, Collin C, Casper ES, Hajdu SI, Brennan MF. The changing role of amputation for soft tissue sarcoma of the extremity in adults. Surg Gynecol Obstet. 1992; 175:389-396.
12. DeLaney TF, Spiro IJ, Suit HD, et al. Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int J Radiat Oncol Biol Phys. 2003; 56:1117-1127.
13. Zagars GK, Ballo MT, Pisters PW, et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 225 patients. Cancer. 2003; 97:2530-2543.
14. Morton MJ, Berquist TH, McLeod RA, Unni KK, Sim FH. MR imaging of synovial sarcoma. AJR Am J Reoentgenol. 1991; 156:337-340.
15. Koscielniak E, Morgan M, Treuner J. Soft tissue sarcoma in children: prognosis and management. Paediatr Drugs. 2002; 4:21-28.
16. Billingsley KG, Lewis JJ, Leung DH, Casper ES, Woodruff JM, Brennan MF. Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma. Cancer. 1999; 85:389-395.
17. Rosen G, Forscher C, Lowenbraun S, et al. Synovial sarcoma. Uniform response of metastases to high dose ifosfamide. Cancer. 1994; 73:2506-2511.
18. Fontanesi J, Pappo AS, Parham DM, et al. Role of irradiation in management of synovial sarcoma: St. Jude Children's Research Hospital experience. Med Pediatr Oncol. 1996; 26:264-267.
19. Machen SK, Easley KA, Goldblum JR. Synovial sarcoma of the extremities: a clinicopathologic study of 34 cases, including semi-quantitative analysis of spindled, epithelial, and poorly differentiated areas. Am J Surg Pathol. 1999; 23:268-275.
20. Ladenstein R, Treuner J, Koscielniak E, et al. Synovial sarcoma of childhood and adolescence. Report of the German CWS-81 study. Cancer. 1993; 71:3647-3655.
21. Ulmer C, Kettelhack C, Tunn PU, Reichardt P, Hohenberger P, Schlag PM. Synovial sarcoma of the extremities. Results of surgical and multimodal therapy [in German]. Chirurg. 2003; 74:370-374.
22. Lewis JJ, Antonescu CR, Leung DH, et al. Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J Clin Oncol. 2000; 18:2087-2094.
23. Okcu MF, Munsell M, Treuner J, et al. Synovial sarcoma of childhood and adolescence: a multicenter, multivariate analysis of outcome. J Clin Oncol. 2003; 21:1602-1611.
24. Frustaci S, Gherlinzoni F, De Paoli F, et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol. 2001; 19:1238-1247.
25. Wright PH, Sim FH, Soule EH, Taylor WF. Synovial sarcoma. J Bone Joint Surg Am. 1982; 64:112-122.
26. Singer S, Baldini EH, Demetri GD, et al. Synovial sarcoma: prognostic significance of tumor size, margin of resection, and mitotic activity for survival. J Clin Oncol. 1996; 14:1201-1208.
27. Kawai A, Woodruff J, Healey JH, Brennan MF, Antonescu CR, Ladanyi M. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med. 1998; 338:153-160.
28. Fligman I, Lonardo F, Jhanwar SC, Gerald WL, Woodruff J, Ladanyi M. Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-SSX2 fusion transcript. Am J Pathol. 1995; 147:1592-1599.
29. Antonescu CR, Kawai A, Leung DH, et al. Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma. Diagn Mol Pathol. 2000; 9:1-8.
30. Ladanyi M, Antonescu CR, Leung DH, et al. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma, a multi-institutional retrospective study of 243 patients. Cancer Res. 2002; 62:135-140.
31. Clark J, Rocques PJ, Crew AJ, et al. Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet. 1994; 7:502-508.
32. Blakely ML, Spurbeck WW, Pappo AS, et al. The impact of margin of resection on outcome in pediatric nonrhabdomyosarcoma soft-tissue sarcoma. J Pediatr Surg. 1999; 34:672-675.
33. Elias A, Ryan L, Aisner J, Antman KH. Mesna, doxorubicin, ifosfamide, dacarbazine (MAID) regimen for adults with advanced sarcoma. Semin Oncol. 1990; 17:41-49.
34. Ferrari A, Gronchi A, Casanova M, et al. Synovial sarcoma: a retrospective analysis of 271 patients of all ages at a single institution. Cancer. 2004; 101:627-634.
35. Kampe CE, Rosen G, Eilber F, et al. Synovial sarcoma. A study of intensive chemotherapy in 14 patients with localized disease. Cancer. 1993; 72:2161-2169.
36. Pappo AS, Fontanesi J, Luo X, et al. Synovial sarcoma in children and adolescents. The St. Jude Children's Research Hospital experience. J Clin Oncol. 1994; 12:2360-2366.
37. Eggermont AM, Schraffordt Koops HS, Klausner JM, et al. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience. Ann Surg. 1996; 224:756-765.
38. Brennan MF. The enigma of local recurrence: The Society of Surgical Oncology. Ann Surg Oncol. 1997; 4:1-12.
39. Pisters PW, Harrison LB, Leung DH, Woodruff JM, Casper ES, Brennan MF. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol. 1996; 14:859-868.
40. Mullen JDR, Zagars GK. Synovial sarcoma outcome following conservation surgery and radiotherapy. Radiother Oncol. 1994; 33:23-30.
41. Deshmukh R, Mankin HJ, Singer S. Synovial sarcoma, the importance of size and location for survival. Clin Orthop Relat Res. 2004; 419:155-161.
42. Skytting B. Synovial sarcoma. A Scandinavian Sarcoma Group project. Acta Orthop Scand. 2000; 291(suppl):S1-S28.